Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dopamine D3 Receptor in Parkinson Disease: A Prognosis Biomarker and an Intervention Target

Current topics in behavioral neurosciences(2022)10.1007/7854_2022_373Source: DataRank Database

Dopamine D3 Receptor in Parkinson Disease: A Prognosis Biomarker and an Intervention Target is a research paper published in Current topics in behavioral neurosciences (2022). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.34)OA: greenTopics (44)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (1)

Jinbin Xu ORCID

Live enrichment

PubMed:35711029 OpenAlex:https://openalex.org/W4283072589

National Institutes of Health

Grant: 5R01NS092865-03

POSTMORTEM VALIDATION OF BIOMARKERS FOR IMAGING PARKINSON DISEASE

NINDS NIH HHS

Grant: R01 NS092865

NINDS NIH HHS

Grant: R01 NS123571

NINDS NIH HHS

Grant: R03 NS090214

FWCI

1.34

Citation Percentile

0.8%

Citation Trend

2024

2026

greenLicense: Springer Nature TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10034716/pdf/nihms-1880635.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/7854_2022_373

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10034716

book serieshttps://doi.org/10.1007/7854_2022_373

Fields of Study

Parkinson's Disease Mechanisms and TreatmentsNeurological disorders and treatmentsNerve injury and regeneration03 medical and health sciences0302 clinical medicineHumansParkinson DiseaseReceptors, Dopamine D3Cross-Sectional StudiesDopamineReceptors, Dopamine D1Prognosis

MeSH Terms

Cross-Sectional StudiesDopamineHumansParkinson DiseasePrognosisReceptors, Dopamine D1Receptors, Dopamine D3

Keywords

Dopamine receptor D3NeuroinflammationParkinson's diseaseNeuroprotectionBiomarkerMedicineDopamine receptor D2DopamineInternal medicineNeuroscienceDiseaseOncologyPsychologyBiologyCross-Sectional StudiesReceptors, Dopamine D1Receptors, Dopamine D3HumansParkinson DiseasePrognosisBDNFDopamine D3 receptorProgressionSurvivalα-Synuclein

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being